Publicaciones en colaboración con investigadores/as de Hospital Universitario 12 de Octubre (35)

2023

  1. Finerenone protects against progression of kidney and cardiovascular damage in a model of type 1 diabetes through modulation of proinflammatory and osteogenic factors

    Biomedicine and Pharmacotherapy, Vol. 168

  2. Imbalance in Bone Morphogenic Proteins 2 and 7 Is Associated with Renal and Cardiovascular Damage in Chronic Kidney Disease

    International Journal of Molecular Sciences, Vol. 24, Núm. 1

2022

  1. Impact of COVID-19 in nutritional and functional status of survivors admitted in intensive care units during the first outbreak. Preliminary results of the NUTRICOVID study

    Clinical Nutrition, Vol. 41, Núm. 12, pp. 2934-2939

  2. Registro del Grupo NADYA-SENPE de Nutrición Enteral Domiciliaria en España: años 2018 y 2019

    Nutricion hospitalaria, Vol. 39, Núm. 1, pp. 223-229

2021

  1. Evaluation of Myocardial Function Following SADI-S

    Obesity Surgery, Vol. 31, Núm. 7, pp. 3109-3115

2020

  1. Finerenone Reduces Intrinsic Arterial Stiffness in Munich Wistar Frömter Rats, a Genetic Model of Chronic Kidney Disease

    American Journal of Nephrology, Vol. 51, Núm. 4, pp. 294-303

  2. Home and Ambulatory Artificial Nutrition (NADYA) group report. Home parenteral nutrition in Spain, 2018

    Nutricion Hospitalaria, Vol. 37, Núm. 2, pp. 403-407

2019

  1. Effect of risk of malnutrition on 30-day mortality among older patients with acute heart failure in Emergency Departments

    European Journal of Internal Medicine, Vol. 65, pp. 69-77

  2. Equalization of four cardiovascular risk algorithms after systematic recalibration: Individual-participant meta-analysis of 86 prospective studies

    European Heart Journal, Vol. 40, Núm. 7, pp. 621-631

  3. Spanish home enteral nutrition registry of the year 2016 and 2017 from the NADYA-SENPE Group

    Nutricion Hospitalaria, Vol. 36, Núm. 1, pp. 233-237

2018

  1. Finerenone attenuates endothelial dysfunction and albuminuria in a chronic kidney disease model by a reduction in oxidative stress

    Frontiers in Pharmacology, Vol. 9, Núm. OCT

  2. Home and ambulatory artificial nutrition (NADYA) report. home parenteral nutrition in Spain, 2017

    Nutricion Hospitalaria, Vol. 35, Núm. 6, pp. 1491-1496

2017

  1. Differential proteomic and oxidative profiles unveil dysfunctional protein import to adipocyte mitochondria in obesity-associated aging and diabetes

    Redox Biology, Vol. 11, pp. 415-428

  2. Mild and short-term caloric restriction prevents obesity-induced cardiomyopathy in young zucker rats without changing in metabolites and fatty acids cardiac profile

    Frontiers in Physiology, Vol. 8, Núm. FEB

  3. Nutrición parenteral domiciliaria en españa 2016; informe del grupo de nutrición artificial domiciliaria y ambulatoria nadya

    Nutricion Hospitalaria, Vol. 34, Núm. 6, pp. 1497-1501

  4. Pediatric parenteral nutrition: Clinical practice guidelines from the Spanish Society of Parenteral and Enteral Nutrition (SENPE), the Spanish Society of Pediatric Gastroenterology, Hepatology and Nutrition (SEGHNP) and the Spanish Society of Hospital Pharmacy (SEFH)

    Nutricion Hospitalaria, Vol. 34, Núm. 3, pp. 745-758

  5. Rapid, automated, and specific immunoassay to directly measure matrix metalloproteinase-9-tissue inhibitor of metalloproteinase-1 interactions in human plasma using AlphaLISA technology: A new alternative to classical ELISA

    Frontiers in Immunology, Vol. 8, Núm. JUL

  6. Registro del Grupo NADYA-SENPE de nutrición enteral domiciliaria en España, años 2014 y 2015

    Nutricion Hospitalaria, Vol. 34, Núm. 1, pp. 15-18

2016

  1. Global cardiovascular protection in chronic kidney disease

    Nature Reviews Cardiology, Vol. 13, Núm. 10, pp. 603-608

  2. Role of matrix metalloproteinase-9 in chronic kidney disease: A new biomarker of resistant albuminuria

    Clinical Science, Vol. 130, Núm. 7, pp. 525-538